Enoxaparine Crusia Laboratorios Farmacéuticos Rovi

Enoxaparin Sodium is an anticoagulant medication used to prevent and treat blood clots. It is commonly administered via subcutaneous injection or intravenous use, including during haemodialysis.

Enoxaparin Sodium is primarily used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism. It is also used to prevent blood clots in patients undergoing certain types of surgery or those who are bedridden. Additionally, it is used during haemodialysis to prevent blood clots in the dialysis equipment. The medication works by thinning the blood, making it harder for clots to form.

Common effects of Enoxaparin Sodium may include bruising, bleeding, and pain or irritation at the injection site. Some users may experience nausea, headache, or dizziness. Severe allergic reactions are rare but can occur. It is important to monitor for signs of unusual bleeding or bruising.

Enoxaparin Sodium should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to follow the prescribed dosage and administration instructions carefully. Patients should inform their healthcare provider about any other medications they are taking, as well as any allergies or medical conditions they have. Regular blood tests may be required to monitor the medication's effects.

Enoxaparin Sodium can interact with other medications, including blood thinners, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Alcohol consumption should be avoided as it can increase the risk of bleeding. Patients should also be cautious when taking medications that affect blood clotting, such as aspirin or warfarin.